Gland Pharma has reported results for third quarter ended December 31, 2024 (Q3FY25)
The company has reported 6.62% rise in net profit at Rs 295.12 crore for Q3FY25 as compared to Rs 276.81 crore for the same quarter in the previous year. However, total income of the company decreased by 5.73% at Rs 1075.85 crore for Q3FY25 as compared to Rs 1141.25 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 6.69% rise in its net profit at Rs 204.69 crore for the quarter ended December 31, 2024 as compared to Rs 191.86 crore for the same quarter in the previous year. However, total income of the company decreased by 8.85% at Rs 1442.55 crore for Q3FY25 as compared to Rs 1582.55 crore for the corresponding quarter previous year.
